Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators

Background: Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients’ psychological health. Objective: We sought to improve understanding of the level...

Full description

Bibliographic Details
Main Authors: Sajya M. Singh, BS, Brittney Murray, MS, CGC, Crystal Tichnell, MGC, Rebecca McClellan, CGC, MGC, Cynthia A. James, PhD, CGC, Andreas S. Barth, MD, PhD
Format: Article
Language:English
Published: Elsevier 2021-08-01
Series:Heart Rhythm O2
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666501821001100
_version_ 1819108048490201088
author Sajya M. Singh, BS
Brittney Murray, MS, CGC
Crystal Tichnell, MGC
Rebecca McClellan, CGC, MGC
Cynthia A. James, PhD, CGC
Andreas S. Barth, MD, PhD
author_facet Sajya M. Singh, BS
Brittney Murray, MS, CGC
Crystal Tichnell, MGC
Rebecca McClellan, CGC, MGC
Cynthia A. James, PhD, CGC
Andreas S. Barth, MD, PhD
author_sort Sajya M. Singh, BS
collection DOAJ
description Background: Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients’ psychological health. Objective: We sought to improve understanding of the level of anxiety and depression as well as device acceptance among inherited channelopathy patients with an ICD. Methods: Eligible patients seen at Johns Hopkins Hospital were sent a survey, which included the Hospital Anxiety and Depression Scale (HADS), Cardiac Anxiety Questionnaire (CAQ), and the Florida Patient Acceptance Survey (FPAS). Student t tests and χ2 tests were used to identify associations with abnormal anxiety and depression scores. Results: Among eligible patients (n = 65), 32 individuals (49%) completed the survey. The rate of device-related complications was 34%, and 41% of patients experienced 1 or more ICD shocks. Twelve patients (38%) had an abnormal HADS anxiety subscore and 5 patients (16%) had an abnormal HADS depression subscore (score ≥ 8). Secondary-prevention ICDs were associated with an abnormal HADS anxiety subscore (P = .03). Experiencing ICD shock(s), device complications, age, sex, and family history of sudden cardiac death were not statistically associated with anxiety or depression. Overall, respondents demonstrated high device acceptance by FPAS (79.9 ± 2.9, maximum total score 100) and moderately high cardiac-specific anxiety by CAQ total score (1.53 ± 0.12). Conclusion: A high prevalence of generalized anxiety was identified among inherited channelopathy patients with ICDs. High device acceptance and lack of association with ICD shocks or complications indicate that further research is necessary to understand this increased incidence.
first_indexed 2024-12-22T03:03:44Z
format Article
id doaj.art-f28acb51467f4f43bf6531fcd5ae95ca
institution Directory Open Access Journal
issn 2666-5018
language English
last_indexed 2024-12-22T03:03:44Z
publishDate 2021-08-01
publisher Elsevier
record_format Article
series Heart Rhythm O2
spelling doaj.art-f28acb51467f4f43bf6531fcd5ae95ca2022-12-21T18:41:07ZengElsevierHeart Rhythm O22666-50182021-08-0124388393Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillatorsSajya M. Singh, BS0Brittney Murray, MS, CGC1Crystal Tichnell, MGC2Rebecca McClellan, CGC, MGC3Cynthia A. James, PhD, CGC4Andreas S. Barth, MD, PhD5Johns Hopkins University School of Medicine, Baltimore, Maryland; Address reprint requests and correspondence: Ms. Sajya Singh, Johns Hopkins University School of Medicine, 720 Rutland Avenue, Ross Building 871, Baltimore, MD 21205.Department of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MarylandDepartment of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MarylandBackground: Implantable cardioverter-defibrillators (ICDs) are an effective treatment in some patients with inherited heart disease, including inherited channelopathies, yet they have also been shown to impact patients’ psychological health. Objective: We sought to improve understanding of the level of anxiety and depression as well as device acceptance among inherited channelopathy patients with an ICD. Methods: Eligible patients seen at Johns Hopkins Hospital were sent a survey, which included the Hospital Anxiety and Depression Scale (HADS), Cardiac Anxiety Questionnaire (CAQ), and the Florida Patient Acceptance Survey (FPAS). Student t tests and χ2 tests were used to identify associations with abnormal anxiety and depression scores. Results: Among eligible patients (n = 65), 32 individuals (49%) completed the survey. The rate of device-related complications was 34%, and 41% of patients experienced 1 or more ICD shocks. Twelve patients (38%) had an abnormal HADS anxiety subscore and 5 patients (16%) had an abnormal HADS depression subscore (score ≥ 8). Secondary-prevention ICDs were associated with an abnormal HADS anxiety subscore (P = .03). Experiencing ICD shock(s), device complications, age, sex, and family history of sudden cardiac death were not statistically associated with anxiety or depression. Overall, respondents demonstrated high device acceptance by FPAS (79.9 ± 2.9, maximum total score 100) and moderately high cardiac-specific anxiety by CAQ total score (1.53 ± 0.12). Conclusion: A high prevalence of generalized anxiety was identified among inherited channelopathy patients with ICDs. High device acceptance and lack of association with ICD shocks or complications indicate that further research is necessary to understand this increased incidence.http://www.sciencedirect.com/science/article/pii/S2666501821001100AnxietyBrugada syndromeCardiac electrophysiologyDepressionImplantable cardioverter-defibrillator (ICD)Inherited heart disease
spellingShingle Sajya M. Singh, BS
Brittney Murray, MS, CGC
Crystal Tichnell, MGC
Rebecca McClellan, CGC, MGC
Cynthia A. James, PhD, CGC
Andreas S. Barth, MD, PhD
Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
Heart Rhythm O2
Anxiety
Brugada syndrome
Cardiac electrophysiology
Depression
Implantable cardioverter-defibrillator (ICD)
Inherited heart disease
title Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
title_full Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
title_fullStr Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
title_full_unstemmed Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
title_short Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
title_sort anxiety and depression in inherited channelopathy patients with implantable cardioverter defibrillators
topic Anxiety
Brugada syndrome
Cardiac electrophysiology
Depression
Implantable cardioverter-defibrillator (ICD)
Inherited heart disease
url http://www.sciencedirect.com/science/article/pii/S2666501821001100
work_keys_str_mv AT sajyamsinghbs anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators
AT brittneymurraymscgc anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators
AT crystaltichnellmgc anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators
AT rebeccamcclellancgcmgc anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators
AT cynthiaajamesphdcgc anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators
AT andreassbarthmdphd anxietyanddepressionininheritedchannelopathypatientswithimplantablecardioverterdefibrillators